Ribometrix

Ribometrix is a biotechnology company developing small molecule therapeutics that directly target RNA to treat human diseases. The Ribometrix team leverages its world-leading expertise in 3D structural analysis of RNA to drive its discovery platform, drawing on technologies invented in the laboratory of Ribometrix scientific founder Kevin Weeks, Ph.D.

Ribometrix

Durham, NC

Website

09.30.2019
Vertex and Ribometrix Establish Strategic Collaboration to Discov…

Read More

09.27.2019
Ribometrix Announces $7.8 Million in New Funding to Advance RNA-T…

Read More